Regeneron Takes Full Libtayo Rights As March Into Oncology Progresses

 
• By Jessica Merrill
  
Girl Alone
Regeneron will go it alone with Libtayo • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category